Łobejko K, Mitosek-Szewczyk K, Kurzepa J, Berbecki J, Stelmasiak Z. Bilirubin and uric acid serum levels in patients with relapsing-remitting multiple sclerosis after the first phase of cladribine treatment. Curr. Issues Pharm. Med. Sci. [Internet]. 2025 Apr. 9 [cited 2025 Aug. 17];23(1):137-42. Available from: https://czasopisma.umlub.pl/curipms/article/view/2855